Order Article Reprints

Sesma A, Pardo J, Isla D, M. Gálvez E, Gascón-Ruiz M, Martínez-Lostao L, Moratiel A, Paño-Pardo JR, Quílez E, Torres-Ramón I, et al. Peripheral Blood TCRβ Repertoire, IL15, IL2 and Soluble Ligands for NKG2D Activating Receptor Predict Efficacy of Immune Checkpoint Inhibitors in Lung Cancer. Cancers. 2024; 16(16):2798. https://doi.org/10.3390/cancers16162798

Sesma, Andrea, Julian Pardo, Dolores Isla, Eva M. Gálvez, Marta Gascón-Ruiz, Luis Martínez-Lostao, Alba Moratiel, J. Ramón Paño-Pardo, Elisa Quílez, Irene Torres-Ramón, and et al. 2024. "Peripheral Blood TCRβ Repertoire, IL15, IL2 and Soluble Ligands for NKG2D Activating Receptor Predict Efficacy of Immune Checkpoint Inhibitors in Lung Cancer" Cancers 16, no. 16: 2798. https://doi.org/10.3390/cancers16162798

Sesma, A., Pardo, J., Isla, D., M. Gálvez, E., Gascón-Ruiz, M., Martínez-Lostao, L., Moratiel, A., Paño-Pardo, J. R., Quílez, E., Torres-Ramón, I., Yubero, A., Zapata-García, M., Domingo, M. P., Esteban, P., Sanz Pamplona, R., Lastra, R., & Ramírez-Labrada, A. (2024). Peripheral Blood TCRβ Repertoire, IL15, IL2 and Soluble Ligands for NKG2D Activating Receptor Predict Efficacy of Immune Checkpoint Inhibitors in Lung Cancer. Cancers, 16(16), 2798. https://doi.org/10.3390/cancers16162798